• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LI Jiajun,MA Jun,TIAN Yushun.A preliminary study on anti-tumor activity of combined application of cisplatin and DMPIBPA in vitro[J].Journal Of Pharmaceutical Research,2016,35(3):133-135[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3506times   Download 3164次 QR Code for this article
Scan with your phone!
顺铂与DMPIBPA合用体外抗肿瘤作用研究
李佳军,马军,田玉顺
Font:Larger+|Default|Smaller-
(延边大学药学院,吉林 延边 133002)
摘要:
目的 合成Z-2-(3,5-二甲氧苯基)-3-(4-异丁氧苯基)丙烯腈(DMPIBPA)并初步研究与顺铂(DDP)联合应用时的抗癌活性。方法 以3,5二甲氧基苯甲酸为原料合成DMPIBPA,后用DDP、DMPIBPA及DDP+DMPIBPA分别处理人结肠癌细胞(HCT116)及人正常肝细胞(L-02)细胞,其细胞增殖的抑制程度用四唑盐(MTT)比色法测定。结果 在HCT116细胞中,100 μmol·L-1 DMPIBPA(抑制率为35.3%±5.0%)与250 μmol·L-1 DDP(抑制率为28.9%±1.3%)联合应用时其抑制率为65.4%±2.0%,明显强于单用,而在L-02细胞中仅为36.2%±0.5%。结论 联合应用DDP及DMPIBPA时对HCT116细胞有选择性协同增殖抑制活性,而对L-02无作用。
关键词:  白藜芦醇衍生物  顺铂  联合用药  抗癌活性  四唑盐比色法
DOI:10.13506/j.cnki.jpr.2016.03.003
基金项目:国家自然科学基金(No.81260226)
A preliminary study on anti-tumor activity of combined application of cisplatin and DMPIBPA in vitro
LI Jiajun,MA Jun,TIAN Yushun
(College of Pharmacy,Yanbian University,Yanji 133002,China)
Abstract:
Objective To synthesize Z-2-(3,5-dimethoxyphenyl-3-(4-isobutoxyphenyl)acrylonitrile (abbreviation ‘DMPIBPA’) and preliminarily study the anti-tumor activities of combined application of DMPIBPA with cisplatin(or DDP).Methods DMPIBPA was synthesized with 3,5-dimethoxybenzoic acid as a starting material and HCT116 and L-02 cells were treated with DDP,DMPIBPA and (DDP+DMPIBPA),respectively,and the proliferation inhibitory effects were determined by MTT assays.Results In HCT116 cells,inhibition ratio of DMPIBPA(100 μmol·L-1) was 35.3%±5.0%,and the inhibition ratio of DDP(250 μmol·L-1) was 28.9%±1.3%.When combined use of DMPIBPA(100 μmol·L-1) with DDP(250 μmol·L-1),the inhibition ratio was 65.4%±2.0% in HCT116 cells but was only 36.2%±0.5% in L-02 cells.The growth inhibition activity of combined application of DMPIBPA and DDP significantly stronger than either one compound in HCT116 cells.Conclusion When combined use of DDP and DMPIBPA,it expressed selective and synergistic inhibition effect on HCT116 cells but had not any effect on L-02 cells.
Key words:  Resveratrol derivatives  DDP  Combined application  Anti-tumor activity  MTT assay
Today's Visits:464    Total Visits:2383159
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.